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Background. Nitroblue tetrazolium (NBT) reduction to
formazan has been used as a marker for nitric oxide synthase
(NOS). Since inducible NOS activity is elevated in urine from
patients with urinary tract infections (UTIs), we investigated the
accuracy of NBT reduction as an early predictor of UTIs and
quantified the relationship between inducible NOS and NBT.
Methods. Urine samples from 434 patients were screened for
the presence of UTIs with leukocyte-esterase and nitrite dipsticks
and with NBT reduction. The rapid screening results from each
test were compared to urine culture results. In addition, NBT
reduction parameters were measured in urine pellet at 595 nm
after incubation with one of four factors: NOS cofactors, NOS
inhibitors, NADH, or superoxide dismutase/catalase.
Results. As a urine screening test for UTIs, NBT reduction was
more sensitive with a higher negative predictive accuracy than the
nitrite dipstick. NBT reduction also was more specific with a
higher positive predictive accuracy and negative predictive accu-
racy than the leukocyte-esterase dipstick. In infected urine pellet,
both NADPH, a NOS cofactor, and NADH increased NBT
reduction. Superoxide dismutase/catalase decreased NBT reduc-
tion.
Conclusions. Although NOS may not be the only NBT reducing
enzyme, rapid, visible reduction of NBT is induced in urine from
patients with UTIs.
We found that inducible-nitric oxide synthase (iNOS)
activity is elevated in urine from patients with urinary tract
infections (UTIs) [1–2], primarily in the particulate fraction
of neutrophils [2]. Nitroblue tetrazolium (NBT) conversion
positively correlates with NOS in neurons, macrophages,
and neutrophils [3–7]. NBT reduction occurs within min-
utes and forms a blue-violet, insoluble formazan [8]. NBT
conversion in urine conceivably could be a quick and
precise test for diagnosing UTIs.
In the 1950s and 1960s, reduction of triphenyltetrazolium
chloride by bacteria was used as a screening test for
bacteriuria, however, the test required four hours to per-
form [9, 10]. Currently, screening for UTIs is performed
using the leukocyte-esterase and nitrite tests. Although the
tests take two minutes or less to perform, the leukocyte-
esterase test has a high false positive rate [11] and the
nitrite test exhibits a high false negative rate [12–14]. The
leukocyte-esterase test detects neutrophils in urine, but
neutrophils can be present with no detectable bacteria [11].
Ingestion of ascorbic acid can also lead to false positive
leukocyte-esterase reactions [15]. With the nitrite screening
test, the large false negative rate may be due in part to the
finding that nitrate is reduced to nitrite by organisms such
as E. coli, Proteus, Salmonella, Pseudomonas, and Staphylo-
coccus, but not by organisms such as Enterococcus and
Candida. Inadequate bacterial incubation, low urine pH,
and urinary urobilinogen also contribute to the low sensi-
tivity of the nitrite test [13, 16].
In this study, to identify the effects of NOS regulatory
factors on NBT conversion in isolated urine cells, the NBT
reaction was measured with a NOS cofactor (nicotinamide
adenine dinucleotide phosphate, NADPH) and with a NOS
inhibitor (NG-monomethyl-L-arginine, L-NMMA) [1, 2,
17]. In addition to the correlation of NOS with NBT,
production of superoxide anion also is recognized by NBT
reduction [18]. Macrophages produce either NO, superox-
ide, or both depending on the stimulus [19]. Both NO and
superoxide production are sensitive to diphenyleneiodo-
nium (an inhibitor of NADPH oxidation) [20–22]. Both
NADH and NADPH have been shown to increase the
concentration of superoxide anions, and NADH incubation
with NBT results in a uniform staining in the urothelium, as
well as in the vaginal and endometrial epithelium [23].
Thus, NBT reduction was measured with NADPH, L-
NMMA, diphenyleneiodonium chloride (DPI), NADH or
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with a superoxide/hydrogen peroxide inhibitor (superoxide
dismutase/catalase) [24–26].
In whole urine, leukocyte-esterase and nitrite dipsticks
and the NBT test were performed and compared to urine
culture results. The accuracy in diagnosing UTIs was
determined for each screening test after calculation of
specificity, sensitivity, and predictive accuracy.
METHODS
Urine sample isolation
Random, clean-catch, straight catheter, or indwelling
catheter, urine samples were obtained from the microbiol-
ogy laboratory at Yale-New Haven Hospital immediately
after a small aliquot of the urine sample was plated.
Patients’ symptoms and urine culture results were not
known at the time of NBT analysis. White blood cell
(WBC) counts in the urine sediment were performed by
microscopic examination in the hematology laboratory and
every urine specimen was cultured for bacteria and yeast in
the microbiology laboratory at Yale/New Haven Hospital.
Subject population
A total of 434 urine samples were collected from 172
males and 262 females and analyzed by the leukocyte
esterase, nitrite, and NBT urine screening tests. The aver-
age age of the patients whose urine was analyzed was
47.0 6 1.0 years (range 1 year to 94 years). The average age
of the female patients was 44.9 6 1.3 years (range 3 years
to 94 years) and the average age of the male patients was
50.2 6 1.5 years (range 1 year to 93 years).
A total of 359 urine samples were clearly positive or
negative by microbiology culture testing. When more than
one organism was found in a single urine, the organism with
the greatest number in culture was used for statistical
analysis and comparisons. In terms of “mixed flora” results,
23 mixed flora results when retested within 48 hours of the
urine screen analysis were clearly positive or negative. The
mixed flora results that were not clearly positive or negative
(75 of 434; 17.3%) were computed separately. Because
previous studies evaluating patients with bacterial cystitis
identified significant inflammatory responses with both low
and high organism numbers [27, 28], in this study, a positive
urine culture of one specific organism type was defined two
ways: as $ 104 organisms/ml and as . 105 organisms/ml
(Table 1). The average age of the 359 patients with clearly
positive or negative culture results was 46.2 1 1.2 years
(range 1 year to 92 years). The average age of the female
patients was 43.5 1 1.6 years (range 3 years to 91 years) and
the average age of the male patients was 49.7 1 1.6 years
(range 1 year to 92 years).
Urinary tract infection-screening tests
To screen for leukocyte esterase and nitrite in the urine,
the Chemstrip 2 LN (Boehringer Mannheim Corporation,
Indianapolis, IN, USA) was used according to manufactur-
er’s instructions. With leukocyte-esterase testing, a positive
was defined as greater than “trace.” To screen for NBT
reduction, 80 ml of 0.75 mM NBT, 110 ml of 20 mM Hepes
buffer, pH 7.4, and 10 ml of 10% Triton X-100 were added
to 200 ml of whole urine at room temperature for three
minutes. A positive NBT result was a color change to
blue-violet.
Nitroblue tetrazolium reduction in the presence of nitric
oxide synthase cofactors or inhibitors
Random urine samples were obtained from the microbi-
ology laboratory at the Yale/New Haven Hospital. Each
urine sample was stored on ice and centrifuged (1700 3 g
for 5 min, 4°C). The urine sediment was isolated immedi-
ately and trypan blue solution (0.2%) exclusion and light
microscopy verified the isolation of viable WBCs in the
urine. The urine pellet was resuspended in ice cold PBS (1
ml) and centrifuged 1700 3 g for five minutes. The
resultant urine pellet was resuspended in 20 mM Hepes (pH
7.4), 1.0 M KCl, and 0.1% Triton X-100 and the protein
concentrations of the urine pellet samples were normalized
using the Bradford method with bovine gamma-globulin as
the protein standard (Bio-Rad, Hercules, CA, USA). The
urine pellet suspended in the Hepes solution was incubated
for one hour with either NADPH (100 mM or 1000 mM),
NADH (1000 mM), L-NMMA (1000 mM), DPI (10 mM), or
superoxide (500 U/ml)/catalase (5000 U/ml). The reaction
mixture was, then, incubated with 0.7 mM NBT for eight
minutes at room temperature (200 ml final reaction vol-
ume) [3, 29]. The reaction was stopped with 50 ml of 0.5 N
H2SO4 and 200 ml of dimethyl sulfoxide (DMSO). After
centrifugation at 1700 3 g, the NBT reduction of the
supernatant was measured at 595 nm [30]. A baseline zero
measurement, the NBT reaction mix without urine, was
subtracted from the results.
Table 1. Organisms identified by urine culture
Organism








Escherichia coli 26 38.2 5 20 43.5 2
Klebsiella species 10 14.7 3 7 15.2 2
Candida species 5 7.4 1 4 8.7 0
Enterococcus faecalis 4 5.9 4 2 4.3 2
Staphylococcus coag. (2) 3 4.4 0 3 6.5 0
Enterobacter species 2 2.9 1 2 4.3 1
Pseudomonas species 2 2.9 0 2 4.3 0
Staphylococcus coag. (1) 2 2.9 0 2 4.3 0
Others 14 20.6 5 4 8.7 1
Total 68 19 46 8
Abbreviations are: Coag., coagulase; Staphylococcus coag. (2), Staphy-
lococcus saprophyticus and Staphylococcus epidermidis; Staphylococcus
coag. (1), Staphylococcus aureus; Others include: Citrobacter freundii,
Proteus mirabilis, Salmonella, Serratia, Streptococci viridans, and Acineto-
bacter species.
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Data analysis
Sensitivity, specificity, positive predictive accuracy, and
negative predictive accuracy were calculated using urine
culture results as the gold standard [14]. Results are
expressed as mean 6 SEM. The Chi square test was used to
compare the urine screening tests [31]. Analysis of variance
was used to compare the patients’ sex and age with the
urine screening accuracy of NBT and to correlate the urine
WBC count with NBT results. Incubation parameters were
compared using the Student’s t-test. With incubation, in-
fected urine and non-infected urine were compared using
the unpaired t-test. Significance level is . 95% for all
analyses.
Chemicals
Nitroblue tetrazolium (NBT), NADPH, NADH, Triton
X-100, NG-monomethyl-L-arginine (L-NMMA), DMSO,
superoxide (SOD), and catalase (CAT) were from Sigma
(St Louis, MO, USA). Diphenyleneiodonium chloride
(DPI) is from Alexis (San Diego, CA, USA).
RESULTS
Nitroblue tetrazolium test accuracy in predicting urinary
tract infections
Urine culture results are reported in Table 1. With $ 104
organisms/ml and .105 organisms/ml, respectively, the
NBT test had a sensitivity of 0.72 and 0.83, a specificity of
0.95 and 0.92, a positive predictive accuracy of 0.78 and
0.60, and an negative predictive accuracy of 0.94 and 0.97
(Table 2). With . 104 organisms/ml and .105 organisms/
ml, respectively, the leukocyte-esterase test had a sensitivity
of 0.71 and 0.70, a specificity of 0.80 and 0.76, a positive
predictive accuracy of 0.45 and 0.30, and a negative predic-
tive accuracy of 0.92 and 0.94. The NBT test had a higher
specificity and a higher predictive accuracy, positive and
negative, than the leukocyte-esterase test. With . 104
organisms/ml and .105 organisms/ml, respectively, the
nitrite test had a sensitivity of 0.28 and 0.39, a specificity of
0.98 and 0.98, a positive predictive accuracy of 0.79 and
0.75, and a negative predictive accuracy of 0.85 and 0.92.
The NBT test had a higher sensitivity and negative predic-
tive accuracy than the nitrite test. Using the chi-squared
test, the null hypothesis of homogeneity was rejected when
the leukocyte-esterase, nitrite, and NBT test proportions
were compared (P , 0.001) [31].
Based on the urine culture results ($104 and . 105
organisms/ml), the false negative and false positive results
were counted for the NBT, leukocyte-esterase, and nitrite
screening tests (Table 3). With . 105 organisms/ml, the
NBT test was negative in 8 (17%) of the 46 urine samples
that were positive by urine culture, the leukocyte-esterase
test was negative in 14 of the 46 urine samples (30%) that
were positive by urine culture and the nitrite test was
negative in 28 of the 46 urine samples (61%) that were
positive by urine culture results. With . 105 organisms/ml,
the NBT test was positive in 25 of the 313 samples (8%)
that were negative by urine culture, the leukocyte-esterase
test was positive in 75 of the 313 samples (24%) that were
negative by urine culture, and the nitrite test was positive in
6 of the 313 samples (2%) that were negative by urine
culture. As a screening test for . 105 organisms/ml, the
NBT test had fewer false negative results than both the
leukocyte-esterase test and the nitrite test.
The NBT test gave false positive results 14 times when
infection was defined as $ 104 organisms/ml and 25 times
when infection was defined as .105 organisms/ml (Tables 2
and 3). All urine specimens were cultured for bacteria and
yeast, but not all specimens were cultured for fungi or
viruses. Eight patients with a false positive NBT result were
tested for cytomegalovirus (CMV) and one of these eight
patients had a positive CMV result. One of the 25 patients
with a false positive NBT result had positive blood cultures
but negative urine cultures. Four of the 25 false positive
results occurred in renal transplant patients with rejection,
Table 2. Nitroblue tetrazolium (NBT) tests in screening for urinary
tract infections






Total(1) (2) (1) (2)
(1) 49 14 63 (1) 38 25 63
(2) 19 277 296 (2) 8 288 296
Total 68 291 359 Total 46 313 359
Sensitivity: 49/68 5 0.72 Sensitivity: 38/46 5 0.83
Specificity: 277/291 5 0.95 Specificity: 288/313 5 0.92
PPA: 49/63 5 0.78 PPA: 38/63 5 0.60
NPA: 277/296 5 0.94 NPA: 288/296 5 0.97
Abbreviations are: PPA, positive predictive accuracy; NPA, negative
predictive accuracy. Organism counts less than the defined significant
count are considered as (2) culture growth.
Table 3. Tabulated false negative and false positive results for the
NBT, leukocyte-esterase, and nitrite tests
Organisms/ml
$ 104 .105 $ 104 .105
Positive, 68 Positive, 46 Negative, 291 Negative, 313
False negative False positive
NBT 19/68 8/46 14/291 25/313
27.9% 17.4% 4.8% 8.0%
Leukocyte-
Esterase
20/68 14/46 59/291 75/313
29.4% 30.4% 20.3% 24.0%
Nitrite 49/68 28/465 5/291 6/313
72.1% 60.9% 1.7% 1.9%
Computed are: (1) the number of false (2) NBT, leukocyte-esterase
and nitrite test results in proportion to the (1) urine culture results, and
(2) the number of false (1) NBT, leukocyte-esterase and nitrite test
results in proportion to the (2) urine culture results. When the leukocyte-
esterase, nitrite, and NBT test proportions were compared using the
chi-squared test. P , 0.001.
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not infection. In addition to renal transplant rejection,
patients with false positive NBT tests had prostate cancer,
renal calculi, ureteropelvic junction obstruction, hypospa-
dias, injury secondary to a motor vehicle accident, bone
marrow transplantation, ovarian cancer, pregnancy, and a
history of a cardiovascular accident.
The NBT test gave false negative results 19 times when
infection was defined as $ 104 organisms/ml and 8 times
when infection was defined as .105 organisms/ml (Tables 2
and 3). The NBT test was never positive with enterococcus
(Table 1). In an investigation of experimental cystitis in
mice, a prominent infiltration of neutrophils was found with
E. coli and Staphylococcus epidermidis, but not with Entero-
coccus faecalis [32].
A comparison between urine white blood cell counts and
nitroblue tetrazolium test results
In addition to comparing the NBT and urine culture
results, the WBC count in urine was correlated with NBT
results. The WBC count/high-powered field was signifi-
cantly smaller in NBT negative urine than in NBT positive
urine (3.3 6 0.4 and 18.5 6 2.5, respectively; P 5 0.0001).
Patient demographics and the nitroblue tetrazolium test
results
The male and female patients whose urine was analyzed
were subdivided by age and NBT results in comparison with
urine culture results. The men with UTIs by urine culture
analysis (true positive and false negative NBT results) were
on the average significantly older than all women who
underwent urine culture analysis and older than the men
without UTIs (Table 4). Women with false negative NBT
urine testing were on the average significantly younger than
the men and women in any other group (Table 4).
Comparison between mixed flora-culture results and
urinary tract infection-screening tests
Mixed flora grew in 75 of 434 urine cultures (17.3%). The
NBT test was positive in 14 of 75 of these urine samples
(18.7%), the leukocyte-esterase test was positive in 27 of 75
of these urine samples (36.0%), and the nitrite test was
positive in 1 of 75 of these urine samples (1.3%). With
mixed flora results, the leukocyte-esterase and NBT results
coincided six times. In the instance in which the nitrite test
was positive, both the leukocyte-esterase and the NBT tests
were negative.
Nitroblue tetrazolium reduction in the presence of nitric
oxide synthase cofactors or inhibitors
In the absence of NADPH, NADH, L-NMMA, DPI, or
SOD/CAT, NBT reduction as assessed by absorbance at
595 nm was significantly higher in pellets isolated from
infected urine than from control urine (Table 5). With the
addition of NADPH (1000 mM) or NADH (1000 mM), the
absorbance increased significantly in pellet from both con-
trol and infected urine. NBT activity did not significantly
change in infected or control urine pellet with the addition
of L-NMMA or DPI. Previous studies have shown that
superoxide anion release increased NOS activity and that
SOD/CAT (a superoxide/hydrogen peroxide inhibitor) de-
creased NOS activity in human cell lines [33]. In this study,
addition of SOD/CAT to control urine did not significantly
affect NBT reduction. However, SOD/CAT did signifi-
cantly inhibit NBT reduction in infected urine.
DISCUSSION
The reduction of NBT was measured in urine to assess its
accuracy as a rapid screening test for UTIs and to correlate
Table 4. A comparison between the age and sex of the patients whose
urine was screened for urinary tract infections and the screening
accuracy of nitroblue tetrazolium (NBT) reduction
NBT screening accuracy
True (1) True (2) False (1) False (2)
Total number of
patients
38 288 25 8
Age 54.4 6 3.9 45.3 6 1.3 43.4 6 4.6 50.4 6 6.7
Age range 6–91 1–92 2–91 21–71
Number of men 7 131 12 5
Age of men 71.3 6 5.1 48.7 6 1.8 42.8 6 4.6 61.0 6 5.7
Age range 15–91 1–92 20–74 40–71
Number of
women
31 157 13 3
Age of women 50.6 6 4.4 42.4 6 1.8 44.0 6 8.0 32.7 6 7.6
Age range 6–88 2–91 2–91 21–47
P value 0.037 0.013 0.903 0.024
Results are calculated for patients with . 105 organisms/ml. Probability
(P) is in the comparison of the ages of men and women in each statistical
group [true (1), true (2), false (1), and false (2)].
Table 5. Nitroblue tetrazolium (NBT) reduction in urine pellets from
control and UTI patients
Control urine Infected urine
P[Absorbance]
(2) 0.097 6 0.007 (N 5 21) 0.333 6 0.025 (N 5 16) 0.0001
(1) NADPH
100 mM
0.119 6 0.014 (N 5 7) 0.358 6 0.032 (N 5 9) 0.0001
(1) NADPH
1000 mM
0.132 6 0.007 (N 5 21) 0.507 6 0.032 (N 5 16) 0.0001
(1) NADH
1000 mM
0.129 6 0.010 (N 5 7) 0.645 6 0.090 (N 5 7) 0.0001
(1) L-NMMA
1000 mM
0.107 6 0.010 (N 5 16) 0.379 6 0.030 (N 5 13) 0.0001
(1) DPI
10 mM
0.094 6 0.008 (N 5 16) 0.306 6 0.032 (N 5 13) 0.0001
(1) SOD/
CAT
0.092 6 0.013 (N 5 7) 0.150 6 0.021 (N 5 9) 0.0397
Abbreviations are defined in manuscript. Urine samples were selected
randomly for absorbance testing. Absorbance was measured at 595 nm.
The probability (P) is with the comparison of the control urine and
infected urine statistically analyzed using the unpaired t-test.
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it with NOS activity during inflammation. As a screening
test for UTIs, the NBT test has fewer false negative results
than both the leukocyte-esterase and nitrite tests. The NBT
test has a higher positive and negative predictive accuracy
than the leukocyte-esterase test and a higher negative
predictive accuracy than the nitrite test. The NBT test also
is more specific than the leukocyte-esterase test and more
sensitive than the nitrite test. Both NOS activity and NBT
reduction are increased with UTIs, but L-NMMA and DPI
do not significantly decrease NBT reduction in infected
urine in the absence of NADPH or NADH.
There are several factors to consider, including the
location of the active enzyme, when comparing the effec-
tiveness of the nitrite, leukocyte-esterase, and NBT tests in
screening for UTIs. The conversion of nitrate to nitrite
takes place in specific bacteria [12] and not all inflamma-
tory processes are caused by bacteria. The activity being
assessed with the leukocyte-esterase [11] and NBT tests
[34–35] is located in human cells. Positive leukocyte ester-
ase results correlate with either intact or lysed neutrophils
[36]. Lymphocytes, erythrocytes, bacteria, and renal tissue
cells do not contain esterases.
In our study, NBT results correlate with microscopic
analysis of urine WBCs. NBT positive urine has a signifi-
cantly greater number of WBCs than NBT negative urine.
Neutrophils, monocytes, and eosinophils all have been
found to reduce NBT [37] and mature granulocytes reduce
more NBT than do immature forms [37–38]. Further
investigation of specific WBCs and NBT reduction in urine
over time may demonstrate that NBT reduction levels
correlate not only with bacterial or yeast UTIs, but also
with other inflammatory disease processes including viral
infection and transplant rejection.
Urine samples from transplant patients with transplant
rejection and negative, standard culture results may be
NBT test positive. Previously we found increased NOS
activity in urinary leukocytes obtained from patients with
UTIs [1–2] and also from patients with kidney transplant
rejection who had negative-urine cultures [39]. Although
serum NBT reduction is elevated with UTIs and normal
with transplant rejection [40], urine NBT reduction is
elevated with both UTIs and renal transplant rejection.
Nitrite, on the other hand, a product of the bacterial
conversion of nitrate to nitrite, may be increased with UTIs
but not with transplant rejection [39]. Thus, the combina-
tion of the NBT reduction test and the nitrite test may aid
in the differential diagnosis of kidney transplant rejection
versus infection.
Macrophages and neutrophils produce NO and can
reduce NBT during infection [1, 2, 5–7, 41]. However, NOS
is not the only enzyme involved in NBT reduction [41].
First, in isolated urinary cells, both NADPH and NADH
modulate NBT reduction and the cofactor for NOS is
NADPH, not NADH. Many nonspecific diaphorases, cyto-
chrome oxidases, and hemoproteins utilize both NADPH
and NADH to increase NBT conversion and these factors
may be present in urine [3, 41]. Furthermore, superoxide
dismutase, an inhibitor of superoxide production, signifi-
cantly inhibits NBT reduction in cells from patients with
infected urine. To identify superoxide production, several
previous studies have used NBT as a probe and inhibited
the reduction of NBT with superoxide dismutase [42].
Conclusions
NBT is rapidly reduced to a visible marker by host
inflammatory cells in urine. Previously we found increased
iNOS in urinary leukocytes obtained from patients with
UTIs and with kidney transplant rejection [2, 39]. NBT
conversion to a blue-violet formazan has been shown to
co-localize with NOS activity [3–7]. Although NOS is not
the only enzyme that can reduce NBT, NBT reduction, like
NOS activity, increases with UTIs and other inflammatory
processes. NBT detects the presence of activated inflam-
matory cells in infected urine and identifies patients in need
of further evaluation and treatment for a UTI.
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APPENDIX
Abbreviations used in this article are: CAT, catalase; CMV, cytomeg-
alovirus; DMSO, dimethyl sulfoxide; DPI, diphenyleneiodonium chloride;
iNOS, inducible nitric oxide synthase; L-NMMA, NG-monomethyl-L-
arginine; NADPH, nicotinamide adenine dinucleotide phosphate; NBT,
nitroblue tetrazolium; NO, nitric oxide; NOS, nitric oxide synthase; SOD,
superoxide; UTI, urinary tract infection; WBC, white blood cell.
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